Opioids Market, by Drug Class, Therapeutic Application, and Geography - Trends and Forecast till 2025

Opioids Market, by Drug Class, Therapeutic Application, and Geography - Trends and Forecast till 2025

Opioid drugs bind to opioid receptors that are present in several areas of the nervous system such as the brain and spinal cord. Medically, they are primarily being used for pain relief. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids. However, its application is not limited to pain relief alone and has been successfully used for treatment of various other medical conditions such as diarrhea and cough. Opioid drugs can be broadly divided into two categories, mild and major opioids, on the basis of its efficacy. Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges. Overdose and drug abuse is a major concern, with the situation alarming in developed regions. According to World Drug Report 2017, 29.5 million people suffered from drug use disorders in 2015 and staggering 70% of this 29.5 million were attributed to opioids only.
Market Dynamics
Incidence of chronic pain, which is primarily treated by opioids has witnessed continuous growth over the last decades. According to a report titled Pain in Europe, published in 2006, chronic pain affected around one in five (19%) adults, and prevalence was recorded to be the highest in Norway, Poland, and Italy, where one-fourth of adults were suffering from chronic pain. According to a study titled Prevalence of Chronic Pain in the UK, published in The BMJ (British Medical Journal), in 2013, chronic pain affects between one-third and one-half of the population in the U.K, indicating high prevalence rate. Prevalence rate is similar in other developed countries such as the U.S. Rapidly increasing incidence of chronic pain is thus expected to boost growth of the opioids market over the forecast period.  
However, increasing usage of opioids, has led to increase in its overuse or abuse over the recent past. To tackle this situation, CDC published guidelines for prescribing opioids for chronic pain. Similar efforts to curtail opioid overuse are underway in developed economies of Europe. Such intervention by regulatory bodies are expected to obstruct growth of the opioids market.  
Key Features of the Study:

This report provides in-depth analysis of the opioids market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2016 – 2024, considering 2014 & 2015 as the base years
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global opioids market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans

Key companies covered as a part of this study include Purdue Pharma L.P., Titan Pharmaceuticals, Inc., Boehringer Ingelheim GmbH, Janssen Pharmaceuticals, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Egalet Corporation, Endo Pharmaceuticals Inc., Allergan, Plc, and Pfizer Inc.

Insights from this report will allow marketers and the management authorities of companies to make informed decision with respect to their future product launch, technology upgrades, market expansion, and marketing tactics
The global opioids market report caters to various stakeholders in this industry, including investors, geriatric care service providers, assistive device manufacturers, distributors and suppliers, research and consulting firms, new entrants, and financial analysts
Various strategy matrices used in analyzing the opioids market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

Global Opioids Market, By Drug Class:

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

Global Opioids Market, By Therapeutic Application:

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Global Opioids Market, By Geography:

North America

U.S.

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Canada

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Europe

U.K.

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Germany

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Italy

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

France

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Spain

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Russia

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Rest of Europe

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Asia-Pacific

China

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

India

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Japan

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

ASEAN

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Australia

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

South Korea

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Rest of Asia Pacific

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Latin America

Brazil

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Mexico

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Argentina

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Rest of Latin America

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Middle East

GCC

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Israel

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Rest of Middle East

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Africa

North Africa

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Central Africa

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

South Africa

By Drug Class

Agonist

Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Diphenoxylate
Hydromorphone
Methylphenidate
Oxycodone
Oxymorphone

Antagonist

Buprenorphine
Naloxone
Naltrexone
Methylnaltrexone
Nalbuphine

By Therapeutic Application

Pain Management

Neuropathic Pain
Migraine
Back Pain
Osteoarthritis Pain
Cancer Pain
Others

Cough Treatment
Diarrhea Treatment

Company Profiles

Purdue Pharma*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc.
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc.

“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Therapeutic Application
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Regulatory Scenario
Reimbursement Scenario
Pricing Analysis
New Product Launches
Government Policies and Initiatives
4. Global Opioids Market, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Introduction
Market Share Analysis, 2015 and 2024 (%)
Y-o-Y Growth Analysis, 2014 - 2024
Segment Trends
Agonist
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Codeine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Fentanyl
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Meperidine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Methadone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Morphine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Hydrocodone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Diphenoxylate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Hydromorphone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Methylphenidate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Oxycodone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Oxymorphone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Antagonist
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Buprenorphine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Naloxone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Naltrexone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Methylnaltrexone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
Nalbuphine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million & No. of Units)
5. Global Opioids Market, By Therapeutic Application, 2014 - 2024 (US$ Million & No. of Units)
Introduction
Market Share Analysis, 2015 and 2024 (%)
Y-o-Y Growth Analysis, 2014 - 2024
Segment Trends
Pain Management
Introduction
Market Share Analysis, 2015 and 2024 (%)
Y-o-Y Growth Analysis, 2014 – 2024
Neuropathic Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million)
Migraine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million)
Back Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million)
Osteoarthritis Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million)
Cancer Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million)
Cough Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million)
Diarrhea Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2014 - 2024, (US$ Million)
6. Global Opioids Market, By Regions, 2014 - 2024 (US$ Million & No. of Units)
Introduction
Market Share Analysis, By Region, 2015 and 2024 (%)
Y-o-Y Growth Analysis, For Regions, 2014 - 2024
North America
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-o-Y Growth Analysis, By Country, 2014 - 2024
U.S.
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Canada
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Europe
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-o-Y Growth Analysis, By Country, 2014 - 2024
U.K.
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Germany
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Italy
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
France
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Russia
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Rest of Europe
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Asia Pacific
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-o-Y Growth Analysis, By Country, 2014 - 2024
China
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
India
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Japan
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
ASEAN
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Australia
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
South Korea
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Rest of Asia Pacific
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Latin America
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-o-Y Growth Analysis, By Country, 2014 - 2024
Brazil
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Mexico
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Rest of Latin America
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Africa
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-o-Y Growth Analysis, By Country, 2014 - 2024
Northern Africa
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Central Africa
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
South Africa
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Middle East
Market Share Analysis, By Country, 2015 and 2024 (%)
Y-o-Y Growth Analysis, By Country, 2014 - 2024
GCC Countries
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Israel
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
Rest of Middle East
Country Trends
Market Size and Forecast, By Drug Class, 2014 - 2024 (US$ Million & No. of Units)
Market Size and Forecast, By Therapeutic Application, 2014 - 2024 (US$ Million)
7. Competitive Landscape
Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
Purdue Pharma
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Titan Pharmaceuticals
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Boehringer Ingelheim
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Janssen Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Sanofi
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Mallinckrodt Pharmaceuticals
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Egalet Corporation
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Endo Pharmaceuticals Inc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Allergan Plc
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Pfizer Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Sun Pharmaceuticals
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Future Plans
Analyst Views
8. Section
References
Research Methodology
About Us and Sales Contact
*Browse 130 market data tables and 42 figures on "Opioids Market - Global forecast to 2024”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook